Companies · Healthtech

Intus Care Inc.

PROVIDENCE · Healthtech · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Intus Care Inc. — recommendation, valuation, rhythm, risks.
$25.2M
Total raised · real
4
Rounds
0.0×
Latest step-up
Top 18%
Sector rank · raised
Series A
Latest stage · inferred · Mon Mar 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Intus Care Inc. looks under-valued against its niche peers and is active on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the healthtech sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Under-valued
  • Modeled value is 0.07× the median modeled value of Series A Healthtech companies in 2025–2027 (99 peers) — value vs value, same stage and era.
Active
  • Last raise 4 mo ago; this sector typically re-raises about every 14 months.
  • Raising on or ahead of the sector's normal rhythm.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Healthtech

Intus Care Inc. is one of 2138 Healthtech companies tracked from PROVIDENCE. By capital raised it ranks in the upper tier (ahead of 83% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
6
Investors (latest)
2026-03-16
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$50M$100M$150M$200MSeries A · 2022-09-02 Raised $13M (real) Modeled valuation $130M (est)$13M$130MSeries A2022Pre-Seed · 2022-12-05 Raised $338K (real) Modeled valuation $3.3M (est)$338K$3.3MPre-Seed2022Series A · 2022-12-05 Raised $438K (real) Modeled valuation $4.0M (est)$438K$4.0MSeries A2022Series A · 2024-11-01 Raised $11M (real) Modeled valuation $49M (est)$11M$49MSeries A2024Series A · 2026-03-16 Raised $539K (real) Modeled valuation $1.4M (est)$539K$1.4MSeries A2026+$338K+$438K+$11M+$539KCumulative $26M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Series A$13.1M · 2022
Bridge · Series A-stage$338K · 2022smaller follow-on
Series A extension$438K · 2022
Series A extension$11.1M · 2024
Series A extension$539K · 2026

Stages are modeled from round size (public records carry no series label). No record for: Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 67%.

Modeled valuation trajectory
$1.4M
Base estimate est.
$691K
Conservative case
$2.1M
Upside case
$2.5M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Series Aa $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the healthtech sector profile. Directional, not a quoted figure.

Series A · modeled $130.2M · 2022-09-022022Pre-Seed · modeled $3.3M · 2022-12-05Series A · modeled $4.0M · 2022-12-05Series A · modeled $48.9M · 2024-11-01Series A · modeled $1.4M · 2026-03-162026
Model inputs · modeled:benchmark-stage-stepup-v1
22%
Dilution assumption
Implied ownership sold in the financing.
52%
Survival probability
28% low · 71% high
1.46×/yr
Annual markup
1.84×/yr upside case
0.3 yr
Elapsed time used
0.3 yr actual, capped for stale marks
healthtech
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$7.1M/yr
Capital velocity
3.8 yr
On record since
2022
First round
5
Rounds on file
How it compares to the market

Benchmarked against 2138 companies in Healthtech. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 5.6× above median
This company$25.2M
Sector median$4.5M
Latest round — vs other Series A rounds in sector (real $, this stage) 0.1× of median
This company$539K
Sector median$5.5M
Modeled value — vs sector median (estimate, all stages) 0.0× of median
This company$1.4M
Sector median$33.8M

Raised more than 83% of sector peers (real $). Modeled value above 14% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #96 of 99.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0M$100.0MCapital raised (log)Queen Dental USA Inc · Series A Raised $15.0M · modeled $61.4M (est)Healthplan Data Solutions, Inc. · Series A Raised $16.7M · modeled $56.1M (est)Chronic Care Management, Inc. · Series A Raised $40.6M · modeled $53.7M (est)Mountain Health Technologies, Inc. · Series A Raised $15.2M · modeled $46.4M (est)Modular Medical, Inc. · Series A Raised $17.3M · modeled $45.7M (est)Healthcare Triangle, Inc. · Series A Raised $19.2M · modeled $44.4M (est)Handl Health, Inc. · Series A Raised $15.7M · modeled $40.3M (est)Medical Exercise Inc. · Series A Raised $11.1M · modeled $40.3M (est)Frontera Health, Inc. · Series A Raised $10.0M · modeled $40.1M (est)Prospyr Medical, Inc. · Series A Raised $18.6M · modeled $39.5M (est)Koda Health, Inc. · Series A Raised $12.2M · modeled $39.3M (est)Cooler Heads Care, Inc. · Series A Raised $18.8M · modeled $39.0M (est)Intus Care Inc. (this company) Raised $25.2M · modeled $1.4M (est)Intus Care Inc.
CompanyStageRaised · realValue · estvs peer med.
Queen Dental USA IncSeries A$15.0M$61.4M3.19×
Healthplan Data Solutions, Inc.Series A$16.7M$56.1M2.92×
Chronic Care Management, Inc.Series A$40.6M$53.7M2.79×
Mountain Health Technologies, Inc.Series A$15.2M$46.4M2.42×
Modular Medical, Inc.Series A$17.3M$45.7M2.38×
Healthcare Triangle, Inc.Series A$19.2M$44.4M2.31×
Handl Health, Inc.Series A$15.7M$40.3M2.10×
Medical Exercise Inc.Series A$11.1M$40.3M2.10×
Frontera Health, Inc.Series A$10.0M$40.1M2.09×
Prospyr Medical, Inc.Series A$18.6M$39.5M2.06×
Koda Health, Inc.Series A$12.2M$39.3M2.04×
Cooler Heads Care, Inc.Series A$18.8M$39.0M2.03×
Intus Care Inc. this companySeries A$25.2M$1.4M0.07×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Series A$13.1M2022-09-02$59.5M$130.2M90%
Pre-Seed$338K2022-12-05$1.9M$3.3M90%
Series A$438K2022-12-05$2.0M$4.0M90%
Series A$11.1M2024-11-01$50.5M$48.9M90%
Series A$539K2026-03-16$2.5M$1.4M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Series A$13.1M2022-09-02
    • First recorded raise — entered as Series A.
    • 14 investors on this round.
  2. Pre-Seed$338K2022-12-05
    • Came back fast: 3 mo vs the ~14 mo sector norm.
    • Round 38.7× smaller than the prior — bridge or down round.
    • 5 investors on this round.
  3. Series A$438K2022-12-05
    • Filed alongside the prior round (same month) — likely a tranche or amendment.
    • Round roughly the size of the prior one.
    • 5 investors on this round.
  4. Series A$11.1M2024-11-01
    • Raised again after 23 mo — slower than the ~14 mo sector norm.
    • Round 25.4× larger than the prior — scaling up.
    • 10 investors on this round.
  5. Series A$539K2026-03-16
    • Raised 16 mo later, in step with the ~14 mo sector norm.
    • Round 20.6× smaller than the prior — bridge or down round.
    • 6 investors on this round.
Intelligence
2027 ~Q1
Modeled next raise · ~11mo cadence
$539K
Modeled next size est.range $539K$863K
0.0×
Last step-up
$7.1M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
David Robert Feinberg2022-12
Evan Robert Jackson2022-12
Gilbert Robert Addo2022-12
Jeanette Robert Freed2026-03
John Robert Felton2022-09
Julian Robert Harris2026-03
Marcus Robert Whitney2024-11
William Robert Helman2022-12
Registry & provenance

Intus Care Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1962589
SEC CIK
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
Vsee Health, Inc.HealthtechSeries A$23.6M$2.7Msame sector · same stage
OpenLoop Health, Inc.HealthtechSeries A$21.3M$2.3Msame sector · same stage
G Medical Innovations Holdings Ltd.HealthtechSeries A$20.6M$3.3Msame sector · same stage
KitoTech Medical, Inc.HealthtechSeries A$20.5M$1.0Msame sector · same stage
Imagen Dental Partners, LlcHealthtechSeries A$33.3M$312Ksame sector · same stage
Nudj Health, Inc.HealthtechSeries A$16.4M$1.5Msame sector · same stage
WEconnect Health Management SPCHealthtechSeries A$15.9M$1.1Msame sector · same stage
Prosperity Health Partners LLCHealthtechSeries A$15.6M$3.3Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Integrated Care Partners, Inc.HealthtechSeries B$145.7M90%
Intuity Medical, Inc.HealthtechSeries C$671.8M89%
IWEUS Health CorpHealthtechSeed$34.7M88%
Everus Health, Inc.HealthtechPre-Seed$10.4M87%
What About Health, Inc.HealthtechPre-Seed$7.6M87%
Linus Health, Inc.HealthtechSeries C$859.2M86%
Kaya Care Inc.HealthtechPre-Seed$7.8M86%
Interstate Health Systems, Inc.HealthtechSeed$20.8M85%
Frequently asked
How much funding has Intus Care Inc. raised?
Intus Care Inc. has raised approximately $25.2M in disclosed capital across 4 recorded financing rounds, aggregated from public filings.
What is Intus Care Inc.'s estimated valuation?
Provath's modeled valuation for Intus Care Inc. is approximately $1.4M (modeled range $691K–$2.1M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Intus Care Inc. at?
Intus Care Inc.'s latest modeled financing stage is Series A. Its most recent recorded round closed around Mon Mar 16.
What does Intus Care Inc. do and where is it based?
Intus Care Inc. operates in the Healthtech sector, based in PROVIDENCE.
Explore related

See where Intus Care Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Intus Care Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.